Funding Opportunities

NIH Funding Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for Drug Abuse Prevention Intervention Research (R01)
Notice NOT-DA-14-017 from the NIH Guide for Grants and Contracts
Mon, 28 Jul 2014 12:18:54 EST

Notice of Change to RFA-DA-15-008 "The National Drug Abuse Treatment Clinical Trials Network (UG1)"
Notice NOT-DA-14-018 from the NIH Guide for Grants and Contracts
Tue, 29 Jul 2014 10:41:21 EST

Notice to Extend the Expiration Date of PA-11-235 "Gene-Environment Interplay in Substance Use Disorders (R01)"
Notice NOT-DA-14-019 from the NIH Guide for Grants and Contracts
Thu, 31 Jul 2014 11:15:58 EST

Notice to Extend the Expiration Date of PA-11-236 "Gene-Environment Interplay in Substance Use Disorders (R21)"
Notice NOT-DA-14-020 from the NIH Guide for Grants and Contracts
Thu, 31 Jul 2014 12:11:04 EST

Notice to Extend the Expiration Date of PA-11-237 "Gene-Environment Interplay in Substance Use Disorders (R03)"
Notice NOT-DA-14-021 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 12:45:32 EST

Notice of Modification of Allowable Budgets for Data Deposition in PA-14-154 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R43/R44)"
Notice NOT-GM-14-123 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 03:22:40 EST

Notice of Modification of Allowable Budgets for Data Deposition in PA-14-156 "Extended Development, Hardening and Dissemination of Technologies in Biomedical Computing, Informatics and Big Data Science (R01)"
Notice NOT-GM-14-125 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 03:28:35 EST

Notice of Modification of Allowable Budgets for Data Deposition in PA-14-157 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R41/R42)"
Notice NOT-GM-14-126 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 03:47:22 EST

Notice of Modification of Allowable Budgets for Data Deposition in PA-14-155 "Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science (R01)"
Notice NOT-GM-14-127 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 03:49:11 EST

Notice of NICHD's Participation in PAR-14-255 "Multidisciplinary Studies of HIV and Viral Hepatitis Co-Infection (R01)"
Notice NOT-HD-14-024 from the NIH Guide for Grants and Contracts
Tue, 29 Jul 2014 03:24:11 EST

Notice of NICHD's Participation in PAR-14-254 "Multidisciplinary Studies of HIV and Viral Hepatitis Co-Infection (R21)"
Notice NOT-HD-14-025 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 02:40:17 EST

Notice of Modifications to the National Human Genome Research Institute's Diversity Action Plan
Notice NOT-HG-14-029 from the NIH Guide for Grants and Contracts
Mon, 28 Jul 2014 09:26:23 EST

Notice of NHLBI Discontinuation of Grant Program "Ancillary Studies in Clinical Trials (R01)"
Notice NOT-HL-14-232 from the NIH Guide for Grants and Contracts
Tue, 29 Jul 2014 03:14:28 EST

Notice on Annual Reporting Requirements and Revised Financial Closeout Requirements for NIH Administrative Supplements Awarded to Recover Losses Due to Hurricane Sandy under the Disaster Relief Appropriations Act
Notice NOT-OD-14-112 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 04:01:04 EST

Notice of Clarification for Expanded Program Proposal Budget and Number of Sub Projects Allowed
Notice NOT-OH-14-011 from the NIH Guide for Grants and Contracts
Wed, 30 Jul 2014 03:58:39 EST

Enhancing Cross-National Research within the Health and Retirement Study Family of Studies (R01)
Funding Opportunity RFA-AG-15-015 from the NIH Guide for Grants and Contracts. The purpose of this announcement is to enhance comparability among a specific group of measures in the US Health and Retirement Study and the family of comparable longitudinal aging studies around the world. For the purposes of this FOA, the specific measures are cognition and dementia assessment; personality and non-cognitive-character-skills; social isolation and loneliness; physical activity; and life histories. Enhancing the comparability of these measures will support cross-national behavioral and social research in aging in areas that are of a high priority to the Division of Behavioral and Social Research at National Institute on Aging. Responsive applications will propose activities such as pilot studies; calibration to gold standard measures; or methods to increase item, measure, or construct comparability.
Wed, 30 Jul 2014 12:40:52 EST

NIDDK Physician Scientist Diversity Mentoring Award (K05)
Funding Opportunity RFA-DK-14-005 from the NIH Guide for Grants and Contracts. The purpose of the Clinician Scientist Mentoring Award to Promote Workforce Diversity is to provide support to mid-career health-professional doctorates or equivalent (See Section III) for protected time to devote effort to basic, epidemiological or outcomes research and to act as research mentors to early-stage investigators from diverse backgrounds underrepresented in biomedical and behavioral research. Candidates for this award should have independent, peer-reviewed, research support at the time of award and possess a demonstrated record of mentoring individuals from underrepresented backgrounds. The candidate's research should demonstrate a sustained level of research productivity in the research areas supported by the NIDDK. The long-term objective of this funding opportunity is to provide mentors with protected time to enhance mentoring opportunities for individuals from underrepresented backgrounds, thereby ensuring the availibility of a pool of scientists from diverse backgrounds to facilitate research within the mission areas of the NIDDK.
Tue, 29 Jul 2014 11:26:07 EST

Hazardous Materials Worker Health and Safety Training (U45)
Funding Opportunity RFA-ES-14-008 from the NIH Guide for Grants and Contracts. This FOA issued by the National Institute of Environmental Health Sciences (NIEHS) invites applications for cooperative agreements to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response.The major objective of this FOA is to prevent work-related harm by assisting in the training of workers in how best to protect themselves and their communities from exposure to hazardous materials encountered during hazardous waste operations, hazardous materials transportation, environmental restoration of contaminated facilities or chemical emergency response.A variety of sites, such as those involved with chemical waste cleanup and remedial action and transportation-related chemical emergency response may pose severe health and safety concerns to workers and the surrounding communities.These sites contain a multiplicity of hazardous substances, sometimes unknown substances, and often the site is uncontrolled. A major goal of the Worker Training Program (WTP) is to provide assistance to organizations in developing their institutional competency to provide appropriate model training and education programs.
Mon, 28 Jul 2014 04:01:43 EST

The NIGMS Human Genetic Cell Repository (U42)
Funding Opportunity RFA-GM-15-005 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the NIGMS Human Genetic Cell Repository. The repository will maintain the current collection of cell cultures and DNA samples and will acquire, characterize, and expand high-quality cell samples and distribute cell lines and DNA isolated from them to qualified biomedical researchers.
Thu, 31 Jul 2014 11:00:21 EST

Detect, Define and Measure the Progression of Chronic Traumatic Encephalopathy (U01)
Funding Opportunity RFA-NS-14-012 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to detect, characterize and measure the progression of neurodegeneration in individuals with a probable or possible diagnosis of chronic traumatic encephalopathy (CTE) using brain imaging and other biomarkers. The overall goals are increased knowledge concerning the neurological mechanisms and ways to detect CTE as it evolves over a 3 - 5 year period and the development of a consensus diagnosis to inform clinical trials aimed at preventing or slowing disease progression in the future.
Tue, 29 Jul 2014 08:49:36 EST

NINDS CREATE Devices: Translational and Clinical Studies on the Path to 510(k) (UH2/UH3)
Funding Opportunity PAR-14-295 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE) or IRB approval for a Non-Significant Risk (NSR) study and the following clinical study. It is expected the immediate next steps upon completion of the clinical study will be a 510(k)/510(k) De Novo submission or a larger clinical trial that will lead directly to a 510(k)/510(k) De Novo submission. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and a small clinical study.
Mon, 28 Jul 2014 03:59:09 EST

NINDS CREATE Devices: Translational and Clinical Studies on the Path to 510(k) (U44)
Funding Opportunity PAR-14-296 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE) or IRB approval for a Non-Significant Risk (NSR) study and the following clinical study. It is expected the immediate next steps upon completion of the clinical study will be a 510(k)/510(k) De Novo submission or a larger clinical trial that will lead directly to a 510(k)/510(k) De Novo submission. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and a small clinical study.
Mon, 28 Jul 2014 03:59:44 EST

NINDS CREATE Devices: Translational and Clinical Studies to Inform Final Device Design (UH2/UH3)
Funding Opportunity PAR-14-297 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE) or IRB approval for a Non-Significant Risk (NSR) study and the following clinical study. It is expected that the clinical study will inform a final device design that would have to go through most, if not all, of the preclinical testing on the path to more advanced clinical trials and market approval. This program also supports development of a device to test scientific hypotheses that are not feasible or practical to conduct in animal models, but are critical to enable next-generation devices. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and a small clinical study.
Mon, 28 Jul 2014 03:59:48 EST

NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (UH2/UH3)
Funding Opportunity PAR-14-298 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and Early Feasibility Studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE), with the option of also supporting the following Early Feasibility Study. It is expected the immediate next steps upon completion of the Early Feasibility Study will be a full Feasibility Study and a Pivotal Trial in support of a PMA (Pre-Market Approval) or HDE (Humanitarian Device Exemption). Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and an Early Feasibility Study.
Mon, 28 Jul 2014 03:59:54 EST

NINDS CREATE Devices: Translational and Early Feasibility Studies on the Path to Pre-Market Approval (PMA) or Humanitarian Device Exemption (HDE) (U44)
Funding Opportunity PAR-14-299 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and Early Feasibility Studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE), with the option of also supporting the following Early Feasibility Study. It is expected the immediate next steps upon completion of the Early Feasibility Study will be a full Feasibility Study and a Pivotal Trial in support of a PMA (Pre-Market Approval) or HDE (Humanitarian Device Exemption). Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and an Early Feasibility Study.
Mon, 28 Jul 2014 03:59:59 EST

NINDS CREATE Devices: Translational and Clinical Studies to Inform Final Device Design (U44)
Funding Opportunity PAR-14-300 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications to pursue translational and clinical studies for therapeutic devices to treat neurological disorders. The program will utilize a cooperative agreement mechanism to support the submission of an Investigational Device Exemption (IDE) or IRB approval for a Non-Significant Risk (NSR) study and the following clinical study. It is expected that the clinical study will inform a final device design that would have to go through most, if not all, of the preclinical testing on the path to more advanced clinical trials and market approval. This program also supports development of a device to test scientific hypotheses that are not feasible or practical to conduct in animal models, but are critical to enable next-generation devices. Activities supported in this program include implementation of clinical prototype devices, preclinical safety and efficacy testing, design verification and validation activities, pursuit of regulatory approval for the clinical study, and a small clinical study.
Mon, 28 Jul 2014 04:00:03 EST

NIDDK Central Repositories Non-renewable Sample Access (X01)
Funding Opportunity PAR-14-301 from the NIH Guide for Grants and Contracts. The NIDDK Central Repositories house valuable samples and data from numerous major clinical studies. This FOA allows investigators to apply for access to non-renewable samples from one or more of these studies. Information about the samples available can be found at www.niddkrepository.org. Applicants must provide information from the NIDDK Central Repositories documenting sample availability.
Wed, 30 Jul 2014 11:29:38 EST

NHLBI Career Transition Award for Intramural Fellows (K22)
Funding Opportunity PAR-14-302 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Career Transition Award (K22) program is to provide highly qualified postdoctoral fellows with an opportunity to receive mentored research experience in the NHLBI Division of Intramural Research and then to provide them with funding to facilitate the transition of their research programs as new investigators to extramural institutions. To achieve these objectives, the NHLBI Career Transition Award will support two phases of research:a mentored intramural phase (two years) and an extramural phase (three years), for a total of five years of combined support.Transition from the intramural phase of support to the extramural phase is not automatic.Approval of the transition will be based on the success of the awardees research program as determined by an NHLBI progress review, which will include an evaluation of a research plan to be carried out at the extramural institution.
Wed, 30 Jul 2014 12:49:37 EST